Cochlear Implantation in Pediatric Cases of Unilateral Hearing Loss (CIPUHL)
Hearing Loss, Unilateral
About this trial
This is an interventional treatment trial for Hearing Loss, Unilateral focused on measuring cochlear implant
Eligibility Criteria
i) Inclusion Criteria
Unilateral moderate-to-profound sensorineural hearing loss.
- Unaided residual hearing thresholds that yield a pure tone average (PTA) at frequencies 500 Hz, 1 kHz and 2 kHz of ≥70 dB HL in the ear to be implanted. It is possible that subjects may have hearing at other frequencies not included in this average.
- Hearing thresholds in the contralateral ear of ≤25 dB HL
- Between 3 years, 6 mos and 6 years, 6 mos of age at implantation.
- Anatomically normal cochlear nerve
Cochlear anatomy that is amenable to cochlear implantation as evaluated by imaging (modality at the physician's discretion) including:
- Normal cochlear anatomy or
- Incomplete Partition Type II (IP2) with or without Enlarged Vestibular Aqueduct (EVA) or
- EVA with normal partitioning
- No evidence of progressive hearing loss.
- Willing to undergo 4 week hearing aid trial as warranted based on achieving desired audibility when fitted via real ear desired sensation level (DSL) method.
Aided word recognition in the ear to be implanted of 30% or less as measured with Consonant Nucleus Consonant (CNC) words (50-word list)
- When listening with an appropriately fit hearing aid and masking applied to the contralateral ear (Turner, 2004).
- Aided testing will be conducted in a sound-proof booth with the participant seated 1 meter from the sound source, facing 0° azimuth. Recorded materials will be presented at 60 dB SPL.
- The hearing aid output will be measured using DSL targets.
- Realistic parental expectations: a verbal acknowledgement of the potential benefits and risks, and postoperative variation in performance. For instance, cochlear implantation will not restore normal hearing.
- Willing to obtain recommended meningitis vaccinations per CDC recommendations.
(9) Development and cognition within the normal range as measured by the Leiter-R test of nonverbal intelligence and cognitive abilities and the Bracken Basic Concept Scale -Revised.
(10) Parental commitment to study parameters including being able and willing to participate in evaluation schedule, involvement in prescribed therapy, and travel to investigational site and study-related activities.
ii) Exclusion Criteria
English is not primary language of the home
- Speech perception materials are presented in English
- Parental questionnaires are administered in English
- Conductive hearing loss in either ear
- Compromised auditory nerve
- Ossification of the cochlea
- Inability to participate in follow-up procedures (i.e., unwillingness, geographic location)
- History of condition that contraindicates middle or inner ear surgery or anesthesia (i.e. otitis media refractory to treatment)
- Case of sudden sensorineural hearing loss that has not been first evaluated by a physician
Sites / Locations
- University of North Carolina at Chapel Hill
Arms of the Study
Arm 1
Experimental
Cochlear Implant
Pediatric patients with single sided deafness will receive a cochlear implant in the ear of loss